Literature DB >> 7592961

RhoA and a cytosolic 50-kDa factor reconstitute GTP gamma S-dependent phospholipase D activity in human neutrophil subcellular fractions.

J Y Kwak1, I Lopez, D J Uhlinger, S H Ryu, J D Lambeth.   

Abstract

Receptor activation of phospholipase D has been implicated in signal transduction in a variety of cells. Reconstitution of cell-free guanosine 5'-O-(3-thiotriphosphate)(GTP gamma S)-dependent phospholipase D activity from human neutrophils requires protein factors in both the plasma membrane and the cytosol. We previously proposed that one of the factors is a Ras-family small molecular weight GTPase of the Rho subtype (Bowman, E. P., Uhlinger, D. J., and Lambeth, J. D. (1993) J. Biol. Chem. 268, 21509-21512). Herein, we have used RhoGDI (GDP dissociation inhibitor), an inhibitory Rho-binding protein, to selectively extract Rho-type GTPases from the plasma membrane, and have used immunoprecipitation as well as chromatographic methods to remove cytosolic Rho. Depletion of RhoA from either the plasma membrane or the cytosol resulted in a partial loss in GTP gamma S dependent activity, while removal of RhoA from both fractions resulted in a nearly complete loss in activity. Activity was nearly completely restored by adding purified recombinant RhoA, which showed an EC50 of 52 nM, while Rac1 showed little activity. Cytosol fractionated using DEAE-cellulose chromatography separated ADP-ribosylation factor and Rho from the major activating fraction. Gel exclusion chromatography of this fraction revealed an activating factor of 50 kDa apparent molecular mass. Using RhoA-depleted membranes, reconstitution of phospholipase D activity required both RhoA and the 50-kDa factor. Thus, RhoA along with a non-Rho, non-ADP-ribosylation factor 50-kDa cytosolic factor are both required to reconstitute GTP gamma S-dependent phospholipase D activity by neutrophil plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592961     DOI: 10.1074/jbc.270.45.27093

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Endocytosis and vesicular trafficking of immune complexes and activation of phospholipase D by the human high-affinity IgG receptor requires distinct phosphoinositide 3-kinase activities.

Authors:  D J Gillooly; A J Melendez; A R Hockaday; M M Harnett; J M Allen
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Deactivation of neutrophil NADPH oxidase by actin-depolymerizing agents in a cell-free system.

Authors:  M Tamura; M Kanno; Y Endo
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

3.  Tissue-specific distribution and subcellular distribution of phospholipase D in rat: evidence for distinct RhoA- and ADP-ribosylation factor (ARF)-regulated isoenzymes.

Authors:  J J Provost; J Fudge; S Israelit; A R Siddiqi; J H Exton
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

Review 4.  Phospholipase D: molecular and cell biology of a novel gene family.

Authors:  M Liscovitch; M Czarny; G Fiucci; X Tang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

5.  Effects of Clostridium difficile toxin A and toxin B on phospholipase D activation in human promyelocytic leukemic HL60 cells.

Authors:  K Ohguchi; Y Banno; S Nakashima; N Kato; K Watanabe; D M Lyerly; Y Nozawa
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  Characterization of the regulation of phospholipase D activity in the detergent-insoluble fraction of HL60 cells by protein kinase C and small G-proteins.

Authors:  M N Hodgkin; J M Clark; S Rose; K Saqib; M J Wakelam
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

7.  Monosodium urate-crystal-stimulated phospholipase D in human neutrophils.

Authors:  J Marcil; D Harbour; M G Houle; P H Naccache; S Bourgoin
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

Review 8.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

9.  Phospholipase D stimulates release of nascent secretory vesicles from the trans-Golgi network.

Authors:  Y G Chen; A Siddhanta; C D Austin; S M Hammond; T C Sung; M A Frohman; A J Morris; D Shields
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

Review 10.  Targeting phospholipase D in cancer, infection and neurodegenerative disorders.

Authors:  H Alex Brown; Paul G Thomas; Craig W Lindsley
Journal:  Nat Rev Drug Discov       Date:  2017-02-17       Impact factor: 84.694

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.